导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 2.64% | 1559/4773 |
| 近一周 | -2.40% | 2074/5462 |
| 近一月 | -5.05% | 3017/5421 |
| 近一季 | -8.11% | 2692/5209 |
| 近半年 | -5.99% | 2984/4920 |
| 近一年 | 7.05% | 1363/4366 |
| 近两年 | 62.31% | 1146/2954 |
| 近三年 | 36.88% | 803/2253 |
| 成立以来 | 23.97% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
1.62% 1232/4961 |
16.44% 1569/5312 |
- - |
- - |
| 2025 | 29.91% 1364/4813 |
2.19% 1442/3635 |
3.11% 1155/4076 |
22.67% 1625/4524 |
0.50% 1967/4813 |
| 2024 | 7.08% 1694/3463 |
0.16% 1031/2808 |
-2.20% 1152/3014 |
11.03% 2564/3129 |
-1.54% 1746/3463 |
| 2023 | -5.88% 791/2656 |
5.06% 834/2280 |
-1.85% 534/2385 |
-4.86% 1241/2515 |
-4.06% 855/2655 |
| 2022 | -23.86% 1171/2207 |
-15.08% 1019/1919 |
1.80% 1418/2016 |
-11.08% 490/2113 |
-0.94% 1660/2208 |
| 2021 | 13.92% 347/1822 |
-1.41% 487/1255 |
10.10% 491/1330 |
3.46% 405/1466 |
1.45% 927/1822 |
| 2020 | - - |
- - |
- - |
- - |
- - |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 华富中证港股通创新药指数型发起式A | 1.1464 | 27.24% |
| 嘉实中证港股通创新药指数发起式C | 0.8441 | 26.80% |
| 中欧中证港股通创新药指数发起A | 1.5868 | 26.75% |
| 中欧中证港股通创新药指数发起C | 1.4370 | 26.67% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8762 | 26.58% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8585 | 26.45% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8568 | 26.39% |
| 汇安中证500增强C VS. 长安沪深300非周期A(740101) |